Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease.

Saved in:
Bibliographic Details
Title: Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease.
Authors: Sands BE; Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. bsands@partners.org, Bank S, Sninsky CA, Robinson M, Katz S, Singleton JW, Miner PB, Safdi MA, Galandiuk S, Hanauer SB, Varilek GW, Buchman AL, Rodgers VD, Salzberg B, Cai B, Loewy J, DeBruin MF, Rogge H, Shapiro M, Schwertschlag US
Source: Gastroenterology [Gastroenterology] 1999 Jul; Vol. 117 (1), pp. 58-64.
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print Cited Medium: Print ISSN: 0016-5085 (Print) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0016-5085
DOI:10.1016/s0016-5085(99)70550-0